Maternal glycemic status linked to epigenetic changes

March 9, 2012
Maternal glycemic status linked to epigenetic changes
Maternal glycemic status and adiponectin levels are linked to epigenetic changes in the adiponectin gene (ADIPOQ), according to a study published online March 6 in Diabetes.

(HealthDay) -- Maternal glycemic status and adiponectin levels are linked to epigenetic changes in the adiponectin gene (ADIPOQ), according to a study published online March 6 in Diabetes.

Noting that is the most abundant circulating hormone secreted by adipocytes, Luigi Bouchard, Ph.D., from the Université de Sherbrooke in Canada, and colleagues analyzed the association between maternal glycemic status and methylation of ADIPOQ in placenta tissue, maternal circulating blood cells, and cord blood cells in 98 women with a singleton pregnancy recruited during their first trimester.

The researchers found a significant association between lower DNA methylation levels on the fetal side of the placenta and higher maternal levels during the second trimester, and a significant association between lower DNA methylation levels on the maternal side of the placenta and higher insulin resistance index during the second and third trimesters. In addition, there was also a significant association between lower DNA methylation levels and higher maternal circulating adiponectin levels throughout pregnancy.

"In conclusion, the ADIPOQ DNA methylation profile was associated with maternal glucose status and with maternal circulating adiponectin concentration," Bouchard and colleagues write. "Because adiponectin is suspected to have insulin-sensitizing proprieties, these epigenetic adaptations have the potential to induce sustained glucose metabolism changes in the mother and offspring later in life."

Explore further: Study finds elevated levels of cell-free DNA in first trimester do not predict preeclampsia

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Study finds elevated levels of cell-free DNA in first trimester do not predict preeclampsia

February 11, 2012
In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in Dallas, Texas, researchers will report findings that indicate that elevated levels of cell-free DNA in ...

Maternal smoking causes changes in fetal DNA

May 18, 2011
Children whose mothers or grandmothers smoked during pregnancy are at increased risk of asthma in childhood, but the underlying causes of this are not well understood. Now a new study indicates changes in a process called ...

Another potential risk factor for developing dementia and Alzheimer's disease in women

January 2, 2012
A hormone derived from visceral fat called adiponectin may play a role as a risk factor for development of all-cause dementia and Alzheimer disease (AD) in women, according to a study published Online First by the Archives ...

Recommended for you

Genetic discovery may help better identify children at risk for type 1 diabetes

January 17, 2018
Six novel chromosomal regions identified by scientists leading a large, prospective study of children at risk for type 1 diabetes will enable the discovery of more genes that cause the disease and more targets for treating ...

Thirty-year study shows women who breastfeed for six months or more reduce their diabetes risk

January 16, 2018
In a long-term national study, breastfeeding for six months or longer cuts the risk of developing type 2 diabetes nearly in half for women throughout their childbearing years, according to new Kaiser Permanente research published ...

Women who have gestational diabetes in pregnancy are at higher risk of future health issues

January 16, 2018
Women who have gestational diabetes mellitus (GDM) during pregnancy have a higher than usual risk of developing type 2 diabetes, hypertension, and ischemic heart disease in the future, according to new research led by the ...

Diabetes gene found that causes low and high blood sugar levels in the same family

January 15, 2018
A study of families with rare blood sugar conditions has revealed a new gene thought to be critical in the regulation of insulin, the key hormone in diabetes.

Discovery could lead to new therapies for diabetics

January 12, 2018
New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy ...

Enzyme shown to regulate inflammation and metabolism in fat tissue

January 11, 2018
The human body has two primary kinds of fat—white fat, which stores excess calories and is associated with obesity, and brown fat, which burns calories in order to produce heat and has garnered interest as a potential means ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.